ARS Pharmaceuticals Inc
SPRY10.310USD
+0.030+0.29%
Cierre 10/03, 16:00（ET）Cotizaciones retrasadas 15 min
1.02BCap. mercado
PérdidaP/E TTM
Más Datos de ARS Pharmaceuticals Inc Compañía
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.
Información de ARS Pharmaceuticals Inc
Símbolo de cotizaciónSPRY
Nombre de la empresaARS Pharmaceuticals Inc
Fecha de salida a bolsaDec 04, 2020
Director ejecutivoMr. Richard E. Lowenthal
Número de empleados155
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 04
Dirección11682 El Camino Real, Suite 120
CiudadSAN DIEGO
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal92130
Teléfono18587719307
Sitio Webhttps://ars-pharma.com/
Símbolo de cotizaciónSPRY
Fecha de salida a bolsaDec 04, 2020
Director ejecutivoMr. Richard E. Lowenthal
Ejecutivos de ARS Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard E. Lowenthal
Mr. Richard E. Lowenthal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.83M
-14.34%
Dr. Sarina Tanimoto, M.D.
Dr. Sarina Tanimoto, M.D.
Chief Medical Officer
Chief Medical Officer
4.57M
-10.85%
Mr. Justin Chakma
Mr. Justin Chakma
Chief Business Officer
Chief Business Officer
136.38K
--
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Secretary and Chief Legal Officer
Secretary and Chief Legal Officer
86.26K
-3.33%
Mr. Michael Kelly
Mr. Michael Kelly
Independent Director
Independent Director
83.22K
--
Mr. Brian T. Dorsey
Mr. Brian T. Dorsey
Chief Operating Officer
Chief Operating Officer
7.65K
--
Dr. Laura K. Shawver, Ph.D.
Dr. Laura K. Shawver, Ph.D.
Director
Director
--
--
Dr. Rajeev Dadoo, Ph.D.
Dr. Rajeev Dadoo, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik Shah, Ph.D.
Dr. Pratik Shah, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard E. Lowenthal
Mr. Richard E. Lowenthal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.83M
-14.34%
Dr. Sarina Tanimoto, M.D.
Dr. Sarina Tanimoto, M.D.
Chief Medical Officer
Chief Medical Officer
4.57M
-10.85%
Mr. Justin Chakma
Mr. Justin Chakma
Chief Business Officer
Chief Business Officer
136.38K
--
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Secretary and Chief Legal Officer
Secretary and Chief Legal Officer
86.26K
-3.33%
Mr. Michael Kelly
Mr. Michael Kelly
Independent Director
Independent Director
83.22K
--
Mr. Brian T. Dorsey
Mr. Brian T. Dorsey
Chief Operating Officer
Chief Operating Officer
7.65K
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 3 de sep
Actualizado: mié., 3 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
RA Capital Management, LP
11.07%
OrbiMed Advisors, LLC
8.39%
Deerfield Management Company, L.P.
7.70%
Lowenthal (Richard E)
6.91%
Pratik Shah Living Trust
4.88%
Otro
61.05%
Accionistas
Accionistas
Proporción
RA Capital Management, LP
11.07%
OrbiMed Advisors, LLC
8.39%
Deerfield Management Company, L.P.
7.70%
Lowenthal (Richard E)
6.91%
Pratik Shah Living Trust
4.88%
Otro
61.05%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
21.29%
Investment Advisor
19.12%
Investment Advisor/Hedge Fund
18.57%
Venture Capital
15.15%
Individual Investor
12.08%
Private Equity
8.39%
Corporation
4.88%
Research Firm
2.70%
Sovereign Wealth Fund
0.44%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
372
85.58M
86.60%
-4.54M
2025Q2
367
96.00M
97.76%
-11.66M
2025Q1
380
100.63M
102.48%
-12.75M
2024Q4
345
96.62M
99.42%
-14.07M
2024Q3
320
88.19M
90.90%
-18.52M
2024Q2
291
87.17M
89.94%
-20.35M
2024Q1
289
89.45M
92.60%
-16.44M
2023Q4
280
92.18M
96.08%
-6.49M
2023Q3
283
95.82M
104.35%
+1.21M
2023Q2
278
88.26M
96.94%
-730.20K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
RA Capital Management, LP
10.94M
11.07%
+80.00K
+0.74%
Sep 29, 2025
OrbiMed Advisors, LLC
8.29M
8.39%
--
--
Jun 30, 2025
Deerfield Management Company, L.P.
7.61M
7.7%
-2.11M
-21.74%
Jul 30, 2025
Lowenthal (Richard E)
6.83M
6.91%
-1.14M
-14.34%
Mar 31, 2025
Pratik Shah Living Trust
4.82M
4.88%
--
--
Mar 31, 2025
Tanimoto (Sarina)
4.57M
4.63%
-556.66K
-10.85%
Mar 31, 2025
SR One Capital Management, LP
4.01M
4.06%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.93M
3.98%
+47.01K
+1.21%
Jun 30, 2025
AllianceBernstein L.P.
3.83M
3.87%
-97.01K
-2.47%
Jun 30, 2025
The Vanguard Group, Inc.
3.25M
3.29%
-228.66K
-6.57%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 2 de oct
Actualizado: jue., 2 de oct
Nombre
Proporción
Invesco Dorsey Wright Healthcare Momentum ETF
0.86%
ALPS Medical Breakthroughs ETF
0.67%
First Trust Small Cap Growth AlphaDEX Fund
0.39%
SPDR S&P Biotech ETF
0.23%
First Trust Small Cap Core Alphadex Fund
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.14%
Invesco Nasdaq Biotechnology ETF
0.12%
ProShares Ultra Nasdaq Biotechnology
0.12%
Principal U.S. Small-Cap ETF
0.09%
First Trust Multicap Growth Alphadex Fund
0.08%
Ver más
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.86%
ALPS Medical Breakthroughs ETF
Proporción0.67%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.39%
SPDR S&P Biotech ETF
Proporción0.23%
First Trust Small Cap Core Alphadex Fund
Proporción0.19%
Direxion Daily S&P Biotech Bull 3X Shares
Proporción0.14%
Invesco Nasdaq Biotechnology ETF
Proporción0.12%
ProShares Ultra Nasdaq Biotechnology
Proporción0.12%
Principal U.S. Small-Cap ETF
Proporción0.09%
First Trust Multicap Growth Alphadex Fund
Proporción0.08%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
